Feature

Climb driving transformational therapies in immune-mediated diseases

Climb Bio (NASDAQ:CLYM) is advancing a pipeline of best-in-class, patient-tailored therapeutics to address the unmet needs of complex and clinically-diverse immune-mediated diseases.

February 18, 2025

Feature

MOBILion trailblazing next-gen separation science to reveal what others leave unseen

Closely-held MOBILion Systems is redefining analytical characterization through its next-generation separation science platform that is integrated with high-resolution mass spectrometry to achieve unprecedented...

February 4, 2025

Feature

VICO addressing severe neurological diseases at the source with RNA modulating therapies

Closely-held VICO Therapeutics is developing antisense oligonucleotide (ASO) RNA modulating therapies for patients with severe genetic neurological diseases, including Huntington’s disease (HD) and spinocerebellar...

January 21, 2025

Feature

ROMTech advancing postoperative rehabilitation with unparalleled patient outcomes

Closely-held ROMTech is combining cutting-edge innovation with advanced telemedicine technology, transforming rehabilitation, diagnostics, facilitating seamless remote patient-physician connections for at-home...

January 14, 2025

NEWS

First New Mexico Hospital leverages Perimeter’s AI-driven, wide field OCT margin visualization technology during breast cancer surgery

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

Climb driving transformational therapies in immune-mediated diseases

MOBILion trailblazing next-gen separation science to reveal what others leave unseen

VICO addressing severe neurological diseases at the source with RNA modulating therapies

ROMTech advancing postoperative rehabilitation with unparalleled patient outcomes

NEWS

USPTO grants OS NOA covering manufacturing of OST-HER2

Hemostemix Licences CytoImmune’s BioReactor Technologies

FDA fast tracks BioRestorative’s BRTX-100 in cLDD

MOBILion showcases new mass spectrometry approach at US HUPO conference

AHN launches Ekso Bionics’ transformational robotic exoskeleton technology

First New Mexico Hospital leverages Perimeter’s AI-driven, wide field OCT margin visualization technology during breast cancer surgery

Industry vet John Calcagnini joins Mesirow as a managing director, healthcare sector

Theratechnologies resumes U.S. supply of EGRIFTA SV for HIV

Medicus provides update on Phase 2 study of D-MNA in BCC

Just a few of the companies we’ve highlighted along the way

Subscribe